Sign up to save your podcasts
Or
Share Omidenepag: A New Category of Topical Glaucoma Therapy
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Omidenepag: A New Category of Topical Glaucoma Therapy
Drs. Amanda Bicket and Lori Provencher join Dr. Andrew Pouw to discuss omidenepag isopropyl (Omlonti), the recently FDA-approved eye drop for treating elevated IOP in patients with primary open-angle glaucoma or ocular hypertension.
For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
View all episodes
By American Academy of Ophthalmology
4.9
5050 ratings
Drs. Amanda Bicket and Lori Provencher join Dr. Andrew Pouw to discuss omidenepag isopropyl (Omlonti), the recently FDA-approved eye drop for treating elevated IOP in patients with primary open-angle glaucoma or ocular hypertension.
For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
More shows like Experts InSight
View all
Ophthalmology off the Grid by Eyetube
43 Listeners
New Retina Radio by Eyetube
17 Listeners
JAMA Ophthalmology Author Interviews
5 Listeners
Eyes For Ears
276 Listeners
CRST: The Podcast
8 Listeners
GT: The Podcast
10 Listeners
Headlight in the fog: The Uveitis Podcast
21 Listeners
Pupil Pod
10 Listeners
RETINA Journal Podcasts
10 Listeners
Cataract Coach with Uday Devgan MD
16 Listeners
Ophthalmology Journal
18 Listeners
ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum
0 Listeners
Talking Euretina
1 Listeners
Mayo Clinic Ophthalmology Podcast
19 Listeners
Real World Ophthalmology
3 Listeners